(1R)-(?)-Myrtenal

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

(1R)-(?)-Myrtenal 通过 Akt 增强糖尿病大鼠骨骼肌和肝脏中的 GLUT2，从而改善高血糖。

(1R)-(?)-Myrtenal ameliorates hyperglycemia by enhancing GLUT2 through Akt in the skeletal muscle and liver of diabetic rats.

(?)-Myrtenal ((1R)-(?)-Myrtenal; 0.1-5 mM; for 24 h) exerts strong cytotoxic effect (IC50 = 5.3 mM) on human colon tumour (HT29) and human normal colon epithelial cells (CCD 841 CoTr).

(?)-Myrtenal ((1R)-(?)-Myrtenal; orally; 80 mg/kg/day for 28 days) reveals decreased the levels of plasma glucose, improved the plasma insulin levels, up-regulation of IRS2, Akt and GLUT2 in liver and IRS2, Akt and GLUT4 protein expression in skeletal muscle in diabetic rats induced by single intraperitoneal injection of Streptozotocin (STZ) (40 mg/kg bw).

——

Others

Other Targets

Others

——

——

18486-69-6

150.22

C10H14O

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (665.69 mM)

CC1(C)[C@@H]2C[C@H]1C(C=O)=CC2

——

(-20℃)

With Ice Pack

≥ 2 years